SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Achaz, G., S. Palmer, M. Kearney, F. Maldarelli, J. W. Mellors, J. M. Coffin, and J. Wakeley. 2004. A robust measure of HIV-1 population turnover within chronically infected individuals. Mol. Biol. Evol. 21:19021912.
  • Albert, J., B. Abrahamsson, K. Nagy, E. Aurelius, H. Gaines, G. Nystrom, and E. M. Fenyo. 1990. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. Aids 4:107112.
  • Allen, T. M., D. H. O’Connor, P. Jing, J. L. Dzuris, B. R. Mothe, T. U. Vogel, E. Dunphy, M. E. Liebl, C. Emerson, N. Wilson, et al. 2000. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407:386390.
  • Allen, T. M., M. Altfeld, X. G. Yu, K. M. O'Sullivan, M. Lichterfeld, S. Le Gall, M. John, B. R. Mothe, P. K. Lee, E. T. Kalife, et al. 2004. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J. Virol. 78:70697078.
  • Barrett, R. D. H., L. K. M’Gonigle, and S. P. Otto. 2006. The distribution of beneficial mutant effects under strong selection. Genetics 174:20712079.
  • Barton, N. H., and S. P. Otto. 2005. Evolution of recombination due to random drift. Genetics 169:23532370.
  • Bell, C. H., R. Pantophlet, A. Schiefner, L. A. Cavacini, R. L. Stanfield, D. R. Burton, and I. A. Wilson. 2008. Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization. J. Mol. Biol. 375:969978.
  • Bryson, S., J.-P. Julien, R. C. Hynes, and E. F. Pai. 2009. Crystallographic definition of the epitope promiscuity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5: vaccine design implications. J. Virol. 83:1186211875.
  • Chun, T. W., L. Carruth, D. Finzi, X. Shen, J. A. DiGiuseppe, H. Taylor, M. Hermankova, K. Chadwick, J. Margolick, T. C. Quinn, et al. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183188.
  • Crawford, H., J. G. Prado, A. Leslie, S. Hue, I. Honeyborne, S. Reddy, M. van der Stok, Z. Mncube, C. Brander, C. Rousseau, et al. 2007. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J. Virol. 81:83468351.
  • da Silva, J. 2006. Site-specific amino acid frequency, fitness and the mutational landscape model of adaptation in human immunodeficiency virus type 1. Genetics 174:16891694.
  • da Silva, J.. 2010. An adaptive walk by human immunodeficiency virus type 1 through a fluctuating fitness landscape. Evolution 64:11601165.
  • da Silva, J., M. Coetzer, R. Nedellec, C. Pastore, and D. E. Mosier. 2010. Fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein region. Genetics 185:293303.
  • Drummond, A. J., G. K. Nicholls, A. G. Rodrigo, and W. Solomon. 2002. Estimating mutation parameters, population history and genealogy simultaneously from temporally spaced sequence data. Genetics 161:13071320.
  • Evans, D. T., D. H. O’Connor, P. Jing, J. L. Dzuris, J. Sidney, J. da Silva, T. M. Allen, H. Horton, J. E. Venham, R. A. Rudersdorf, et al. 1999. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat. Med. 5:12701276.
  • Fernandez, C. S., I. Stratov, R. De Rose, K. Walsh, C. J. Dale, M. Z. Smith, M. B. Agy, S.-l. Hu, K. Krebs, D. I. Watkins, et al. 2005. Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost. J. Virol. 79:57215731.
  • Fisher, R. A. 1930. The genetical theory of natural selection. Clarendon Press, Oxford , U.K.
  • Frank, S. A. 2002. Immunology and evolution of infectious disease. Princeton University, Princeton , NJ .
  • Friedrich, T. C., E. J. Dodds, L. J. Yant, L. Vojnov, R. Rudersdorf, C. Cullen, D. T. Evans, R. C. Desrosiers, B. R. Mothe, J. Sidney, et al. 2004. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat. Med. 10:275281.
  • Frost, S. D. W., T. Wrin, D. M. Smith, S. L. K. Pond, Y. Liu, E. Paxinos, C. Chappey, J. Galovich, J. Beauchaine, C. J. Petropoulos, et al. 2005. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc. Natl. Acad. Sci. USA 102:1851418519.
  • Gerrish, P. 2001. The rhythm of microbial adaptation. Nature 413:299302.
  • Gerrish, P. J., and R. E. Lenski. 1998. The fate of competing beneficial mutations in an asexual population. Genetica 102–103:127144.
  • Gillespie, J. H. 1991. The causes of molecular evolution. Oxford Univ. Press, New York .
  • Gillespie, J. H.. 1993. Substitution processes in molecular evolution. I. Uniform and clustered substitutions in a haploid model. Genetics 134:971981.
  • Hamilton, W. D. 1992. Recurrent viruses and theories of sex. Trends Ecol. Evol. 7:277278.
  • Huang, C.-C., M. Tang, M.-Y. Zhang, S. Majeed, E. Montabana, R. L. Stanfield, D. S. Dimitrov, B. Korber, J. Sodroski, I. A. Wilson, et al. 2005. Structure of a V3-containing HIV-1 gp120 core. Science 310:10251028.
  • Huang, C.-C., S. N. Lam, P. Acharya, M. Tang, S.-H. Xiang, S. S.-u. Hussan, R. L. Stanfield, J. Robinson, J. Sodroski, I. A. Wilson, et al. 2007. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 317:19301934.
  • Josefsson, L., M. S. King, B. Makitalo, J. Brännström, W. Shao, F. Maldarelli, M. F. Kearney, W.-S. Hu, J. Chen, H. Gaines, et al. 2011. Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule. Proc. Natl. Acad. Sci USA. 108:1119911204.
  • Kim, Y., and H. A. Orr. 2005. Adaptation in sexuals vs. asexuals: clonal interference and the Fisher-Muller model. Genetics 171:13771386.
  • Kindt, T. J., R. A. Goldsby, B. A. Osborne, and J. Kuby. 2006. Kuby immunology. W. H. Freeman, New York .
  • Le Grand, D., M. Solsona, R. Rosengarten, and F. Poumarat. 1996. Adaptive surface antigen variation in Mycoplasma bovis to the host immune response. FEMS Microbiol. Lett. 144:267275.
  • Leigh Brown, A. J. 1997. Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population. Proc. Natl. Acad. Sci. USA 94:18621865.
  • Leslie, A. J., K. J. Pfafferott, P. Chetty, R. Draenert, M. M. Addo, M. Feeney, Y. Tang, E. C. Holmes, T. Allen, J. G. Prado, et al. 2004. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 10:282289.
  • Mahalanabis, M., P. Jayaraman, T. Miura, F. Pereyra, E. M. Chester, B. Richardson, B. Walker, and N. L. Haigwood. 2009. Continuous viral escape and selection by autologous neutralizing antibodies in drug-naive human immunodeficiency virus controllers. J. Virol. 83:662672.
  • Manrique, A., P. Rusert, B. Joos, M. Fischer, H. Kuster, C. Leemann, B. Niederost, R. Weber, G. Stiegler, H. Katinger, et al. 2007. In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10. J. Virol. 81:87938808.
  • Mansky, L. M., and H. M. Temin. 1995. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69:50875094.
  • Markowitz, M., M. Louie, A. Hurley, E. Sun, M. Di Mascio, A. S. Perelson, and D. D. Ho. 2003. A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J. Virol. 77:50375038.
  • McKeating, J. A., J. Bennett, S. Zolla-Pazner, M. Schutten, S. Ashelford, A. L. Brown, and P. Balfe. 1993. Resistance of a human serum-selected human immunodeficiency virus type 1 escape mutant to neutralization by CD4 binding site monoclonal antibodies is conferred by a single amino acid change in gp120. J. Virol. 67:52165225.
  • McKnight, A., R. A. Weiss, C. Shotton, Y. Takeuchi, H. Hoshino, and P. R. Clapham. 1995. Change in tropism upon immune escape by human immunodeficiency virus. J. Virol. 69:31673170.
  • Mo, H., L. Stamatatos, J. Ip, C. Barbas, P. Parren, D. Burton, J. Moore, and D. Ho. 1997. Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. J. Virol. 71:68696874.
  • Moore, P. L., N. Ranchobe, B. E. Lambson, E. S. Gray, E. Cave, M.-R. Abrahams, G. Bandawe, K. Mlisana, S. S. Abdool Karim, C. Williamson, et al. 2009. Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection. PLoS Pathogens 5:e1000598.
  • Murray, J. M., A. D. Kelleher, and D. A. Cooper. 2011. Timing of the components of the HIV life cycle in productively infected CD4+ T cells in a population of HIV-infected individuals. J. Virol. 85:1079810805.
  • Navis, M., D. Edo Matas, A. Rachinger, F. A. Koning, P. van Swieten, N. A. Kootstra, and H. Schuitemaker. 2008. Molecular evolution of human immunodeficiency virus type 1 upon transmission between human leukocyte antigen disparate donor-recipient pairs. PLoS ONE 3:e2422.
  • Nielsen, R., and Z. Yang. 1998. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148:929936.
  • Nijhuis, M., C. A. B. Boucher, P. Schipper, T. Leitner, R. Schuurman, and J. Albert. 1998. Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. Proc. Natl. Acad. Sci. USA 95:1444114446.
  • Orr, H. A. 2002. The population genetics of adaptation: the adaptation of DNA sequences. Evolution 56:13171330.
  • Otto, S. P., and N. H. Barton. 2001. Selection for recombination in small populations. Evolution 55:19211931.
  • Pantophlet, R., and D. R. Burton. 2006. GP120: target for neutralizing HIV-1 antibodies. Annu. Rev. Immunol. 24:739769.
  • Richman, D. D., T. Wrin, S. J. Little, and C. J. Petropoulos. 2003. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. USA 100:41444149.
  • Rodrigo, A. G., E. G. Shpaer, E. L. Delwart, A. K. Iversen, M. V. Gallo, J. Brojatsch, M. S. Hirsch, B. D. Walker, and J. I. Mullins. 1999. Coalescent estimates of HIV-1 generation time in vivo. Proc. Natl. Acad. Sci. USA 96:21872191.
  • Rong, R., B. Li, R. M. Lynch, R. E. Haaland, M. K. Murphy, J. Mulenga, S. A. Allen, A. Pinter, G. M. Shaw, E. Hunter, et al. 2009. Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. PLoS Pathogens 5:e1000594.
  • Rozen, D. E., J. A. G. M. de Visser, and P. J. Gerrish. 2002. Fitness effects of fixed beneficial mutations in microbial populations. Curr. Biol. 12:10401045.
  • Sanjuan, R., M. R. Nebot, N. Chirico, L. M. Mansky, and R. Belshaw. 2010. Viral mutation rates. J. Virol. 84:97339748.
  • Schneidewind, A., M. A. Brockman, R. Yang, R. I. Adam, B. Li, S. Le Gall, C. R. Rinaldo, S. L. Craggs, R. L. Allgaier, K. A. Power, et al. 2007. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J Virol. 81:1238212393.
  • Schneidewind, A., M. A. Brockman, J. Sidney, Y. E. Wang, H. Chen, T. J. Suscovich, B. Li, R. I. Adam, R. L. Allgaier, B. R. Mothe, et al. 2008. Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid. J. Virol. 82:55945605.
  • Seo, T. K., J. L. Thorne, M. Hasegawa, and H. Kishino. 2002. Estimation of effective population size of HIV-1 within a host: a pseudomaximum-likelihood approach. Genetics 160:12831293.
  • Shibata, J., K. Yoshimura, A. Honda, A. Koito, T. Murakami, and S. Matsushita. 2007. Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolate. J. Virol. 81:37573768.
  • Shriner, D., R. Shankarappa, M. A. Jensen, D. C. Nickle, J. E. Mittler, J. B. Margolick, and J. I. Mullins. 2004. Influence of random genetic drift on human immunodeficiency virus type 1 env evolution during chronic infection. Genetics 166:11551164.
  • Stanfield, R. L., M. K. Gorny, C. Williams, S. Zolla-Pazner, and I. A. Wilson. 2004. Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447–52D. Structure (Camb) 12:193204.
  • Templeton, A. R., R. A. Reichert, A. E. Weisstein, X.-F. Yu, and R. B. Markham. 2004. Selection in context: patterns of natural selection in the glycoprotein 120 region of human immunodeficiency virus 1 within infected individuals. Genetics 167:15471561.
  • Watkins, B. A., S. Buge, K. Aldrich, A. E. Davis, J. Robinson, M. S. Reitz, Jr., and M. Robert-Guroff. 1996. Resistance of human immunodeficiency virus type 1 to neutralization by natural antisera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites. J. Virol. 70:84318437.
  • Wei, X., J. M. Decker, S. Wang, H. Hui, J. C. Kappes, X. Wu, J. F. Salazar-Gonzalez, M. G. Salazar, J. M. Kilby, M. S. Saag, et al. 2003. Antibody neutralization and escape by HIV-1. Nature 422:307312.
  • Williamson, S. 2003. Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression. Mol. Biol. Evol. 20:13181325.
  • Xiang, S.-H., A. Finzi, B. Pacheco, K. Alexander, W. Yuan, C. Rizzuto, C.-C. Huang, P. D. Kwong, and J. Sodroski. 2010. A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer. J. Virol. 84:31473161.
  • Yoshiyama, H., H. Mo, J. P. Moore, and D. D. Ho. 1994. Characterization of mutants of human immunodeficiency virus type 1 that have escaped neutralization by a monoclonal antibody to the gp120 V2 loop. J. Virol. 68:974978.
  • Yusim, K., B. T. M. Korber, C. Brander, B. F. Haynes, R. Koup, J. P. Moore, B. D. Walker, and D. I. Watkins, eds. 2009. HIV molecular immunology 2009. Los Alamos National Laboratory, Theoretical Biology and Biophysics, Los Alamos , NM .
  • Zolla-Pazner, S. 2004. Identifying epitopes of HIV-1 that induce protective antibodies. Nat. Rev. Immunol. 4:199210.
  • Zwick, M. B., R. Jensen, S. Church, M. Wang, G. Stiegler, R. Kunert, H. Katinger, and D. R. Burton. 2005. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1. J. Virol. 79:12521261.